Does ALOGLIPTIN Cause Pancreatic carcinoma? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Pancreatic carcinoma have been filed in association with ALOGLIPTIN (Alogliptin and Pioglitazone). This represents 1.6% of all adverse event reports for ALOGLIPTIN.
22
Reports of Pancreatic carcinoma with ALOGLIPTIN
1.6%
of all ALOGLIPTIN reports
6
Deaths
6
Hospitalizations
How Dangerous Is Pancreatic carcinoma From ALOGLIPTIN?
Of the 22 reports, 6 (27.3%) resulted in death, 6 (27.3%) required hospitalization, and 10 (45.5%) were considered life-threatening.
Is Pancreatic carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALOGLIPTIN. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does ALOGLIPTIN Cause?
Pemphigoid (98)
Pancreatitis (66)
Diarrhoea (60)
Nausea (60)
Rash (55)
Hypoglycaemia (46)
Vomiting (44)
Pancreatitis acute (43)
Drug ineffective (42)
Pruritus (42)
What Other Drugs Cause Pancreatic carcinoma?
RANITIDINE (15,752)
SITAGLIPTIN (1,142)
PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE (838)
EXENATIDE (781)
LIRAGLUTIDE (680)
METFORMIN\SITAGLIPTIN (431)
PACLITAXEL (325)
SEMAGLUTIDE (237)
DULAGLUTIDE (229)
ADALIMUMAB (213)
Which ALOGLIPTIN Alternatives Have Lower Pancreatic carcinoma Risk?
ALOGLIPTIN vs ALOGLIPTIN\METFORMIN
ALOGLIPTIN vs ALOGLIPTIN\PIOGLITAZONE
ALOGLIPTIN vs ALOSETRON
ALOGLIPTIN vs ALPELISIB
ALOGLIPTIN vs ALPHA.-LIPOIC ACID